Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study
Yalan et al., BMC Pharmacology and Toxicology, doi:10.1186/s40360-024-00753-7
https://c19early.org/yalan.html